SCHEMBL3677252

SCHEMBL3677252

CCC#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=NO)CC[C@@H]4[C@H]3CC[C@@H]21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 4/20 0.59
▸ NR3C1 P04150 3/20 0.59
▸ SLC6A4 P31645 3/20 0.59
▸ NR1I2 O75469 2/20 0.59
▸ ADORA3 P0DMS8 2/20 0.59
▸ SLC6A2 P23975 2/20 0.59
▸ AGTR1 P30556 1/20 0.59
▸ DRD3 P35462 1/20 0.59
▸ SLC6A3 Q01959 1/20 0.59
▸ PDE4D Q08499 1/20 0.59
▸ PDK1 Q15118 4/20 0.50
▸ PDK2 Q15119 4/20 0.50
▸ PDK3 Q15120 4/20 0.50
▸ PDK4 Q16654 4/20 0.50
▸ CYP3A4 P08684 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ CYP2C19 P33261 3/20 0.42
▸ AR P10275 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22382729 0.75 PGR (0.57) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL38318 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL38317 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL633395 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL15233395 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL1411821 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL5523236 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL5173707 0.74 PGR (1.00) PGRNR3C1SLC6A4NR1I2ADORA3
SCHEMBL6462145 0.73 PGR (0.49) PGRNR3C1SLC6A4NR1I2ADORA3
Norgestimate SCHEMBL28685734 0.73 PGR (0.98) PGRNR3C1SLC6A4NR1I2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003082336-A1 FEMALE BIRTH CONTROL METHOD JENCAP RESEARCH LTD. (CA) 2003-10-09 — — WO claimed
US-20100063019-A1 Low Dose Estrogen Interrupted Hormone Replacement Therapy DURAMED PHARMACEUTICALS, INC. (US) 2010-03-11 — — US disclosed
US-20080182828-A1 Low Dose Estrogen Interrupted Hormone Replacement Therapy DURAMED PHARMACEUTICALS, INC. (US) 2008-07-31 — — US disclosed
US-7320970-B2 Low dose estrogen interrupted hormone replacement therapy DURAMED PHARMACEUTIALS, INC. (US) 2008-01-22 — — US disclosed
US-20060211663-A1 Low dose estrogen interrupted hormone replacement therapy DURAMED PHARMACEUTICALS, INC. (US) 2006-09-21 — — US disclosed
US-7078394-B2 Low dose estrogen interrupted hormone replacement therapy DURAMED PHARMACEUTICALS, INC. (US) 2006-07-18 — — US disclosed
EP-1140109-B1 TRIPHASIC ORAL CONTRACEPTIVE ORTHO MCNEIL PHARM INC (US) 2006-03-01 — — EP disclosed
US-20050038006-A1 Triphasic oral contraceptive SHANGOLD GARY A (US) 2005-02-17 — — US disclosed
US-20040180867-A1 Low dose estrogen interrupted hormone replacement therapy DURAMED PHARMACEUTICALS, INC. 2004-09-16 — — US disclosed
US-6747019-B2 MIXTURE OF ESTROGEN, PROGESTERONE; ALTERNATING DOSAGE JENCAP RESEARCH, LTD. (CA) 2004-06-08 — — US disclosed
US-20020165209-A1 Low dose estrogen interrupted hormone replacement therapy JENCAP RESEARCH LTD. 2002-11-07 — — US disclosed
EP-1165183-A1 LOW DOSE ESTROGEN INTERRUPTED HORMONE REPLACEMENT THERAPY JENCAP RESEARCH LIMITED (CA) 2002-01-02 — — EP disclosed
US-20010044429-A1 Triphasic oral contraceptive SHANGOLD GARY A (US) 2001-11-22 — — US disclosed
US-6214815-B1 ETHINYLESTRADIOL AND NORGESTIMATE MIXTURES FOR CYCLES ORTHO-MCNEIL PHARMACEUTICALS, INC. 2001-04-10 — — US disclosed
WO-2000059577-A1 LOW DOSE ESTROGEN INTERRUPTED HORMONE REPLACEMENT THERAPY JENCAP RESEARCH LTD. (CA) 2000-10-12 — — WO disclosed
Send feedback